References | Country | Study design | Duration | Fixation methods | No. of patients | Age (years) | Â | Gender (M/F) | Â | Neer type | Follow-up (months) | Â | Outcomes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wang et al. [56] | China | Retrospective | 2014.8–2018.4 | HP/LCP | 64 (33/31) | 37.0 ± 10.0 | 38.8 ± 8.6 | 21/12 | 19/12 | II | 12 |  | 1, 2, 4, 5, 6, 7, 8 |
Li et al. [47] | China | Retrospective | 2015.1–2017.5 | HP/LCP | 44 (26/18) | 51.7 ± 17.1 | 55.2 ± 16.3 | 16/10 | 11/7 | II, V | 17.2 (13–19) |  | 1, 4, 6, 7, 8 |
Chen et al. [21] | USA | Retrospective | 2009–2019 | HP/LCP | 31 (12/19) | 40 ± 15 | 44 ± 13 | 10/2 | 15/4 | II, V | 31 ± 31 | 40 ± 36 | 4 |
Ochen et al. [50] | Netherlands | Retrospective | 2011.1–2016.6 | HP/LCP | 67 (19/48) | 42 ± 17 | 43 ± 12 | 13/6 | 41/7 | II, V | 31.3 ± 16.3 | 40.0 ± 18.0 | 4 |
Singh et al. [52] | USA | Retrospective | 2010.1–2012.9 | HP/LCP | 53 (16/37) | 31.7 ± 16.0 | 36.2 ± 15.9 | 10/6 | 27/10 | II, V | NR |  | 4 |
Xiong et al. [58] | China | Retrospective | 2001–2010 | HP/LCP | 30 (25/5) | 46.5 ± 15.8 | 38.0 ± 14.7 | 34/24 |  | II | 77.4 ± 34.6 | 76.2 ± 72.4 | 4, 5, 6, 7 |
Erdle et al. [38] | Germany | Retrospective | 2004–2016 | HP/LCP | 32 (19/13) | 44.3 ± 14.9 | 43.7 ± 13.7 | NR |  | IIB | 54.9 ± 19.8 | 53.3 ± 19.6 | 1, 4 |
Cai et al. [34] | China | Prospective | 2011.3–2013.3 | HP/LCP | 40 (20/20) | 33.3 ± 7.5 | 32.9 ± 6.6 | 15/5 | 16/4 | II | NR |  | 2, 4, 6, 7 |
Zhu et al. [65] | China | Retrospective | 2008.1–2011.12 | HP/LCP | 46 (26/20) | 40.3 (20–57) |  | 31/15 |  | II | NR |  | 1, 4, 8 |
Zhang et al. [60] | China | Retrospective | 2007.2–2010.11 | HP/LCP | 66 (30/36) | 41.1 ± 10.3 | 42.5 ± 10.7 | 17/13 | 20/16 | II | 27.2 ± 6.1 | 28.6 ± 6.2 | 1, 4 |
Tan et al. [53] | China | Retrospective | 2007–2009 | HP/LCP | 42 (23/19) | 41.8 ± 11.1 | 40.5 ± 9.6 | 15/8 | 13/6 | II | 22.1 ± 9.3 | 22.4 ± 10.1 | 2, 4, 6, 8 |
Dai et al. [36] | China | Retrospective | 2008.1–2009.1 | HP/LCP | 45 (25/20) | 35.6 (21–46) | 36.5 (24–51) | 17/8 | 13/7 | II | 15.6 (12–24) |  | 4 |
Wang et al. [67] | China | Retrospective | 2014.10–2016.10 | HP/CC | 50 (25/25) | 44.8 ± 13.9 | 43.3 ± 14.3 | 15/10 | 19/6 | IIB | 12.7 ± 4.0 |  | 4, 5, 6, 7 |
Wu et al. [20] | China | Prospective | 2015.10–2018.2 | HP/CC | 26 (14/12) | 48.9 ± 16.5 | 44.8 ± 10.3 | 8/6 | 9/3 | II | 18.9 ± 3.5 | 17.0 ± 4.2 | 1, 2, 4, 5, 6, 7 |
Singh et al. [52] | USA | Retrospective | 2010.1–2012.9 | HP/CC | 37 (16/21) | 31.7 ± 16.0 | 43.8 ± 19.6 | 10/6 | 16/4 | II, V | NR |  | 4 |
Xiang et al. [62] | China | Retrospective | 2009.1–2015.10 | HP/CC | 66 (34/32) | 40.2 ± 11.4 | 41.8 ± 12.7 | 26/8 | 22/10 | IIB | 30.5 ± 7.1 | 29.1 ± 5.6 | 1, 4, 6, 8 |
Xiong et al. [58] | China | Retrospective | 2001–2014 | HP/CC | 53 (25/28) | 46.5 ± 15.8 | 41.9 ± 13.5 | 34/24 |  | II | 77.4 ± 34.6 | 35.6 ± 13.9 | 4, 5, 7 |
Hsu et al. [44] | China (TW) | Retrospective | 2010–2014 | HP/CC | 72 (49/23) | 47.9 ± 19.5 | 42.4 ± 15.9 | 29/20 | 16/7 | II, V | 13.3 ± 2.5 | 14.2 ± 1.9 | 1, 2, 4, 8 |
Xu et al. [59] | China | Retrospective | 2013.4–2015.6 | HP/CC | 42 (22/20) | 33.8 ± 10.7 | 37.7 ± 9.9 | 14/8 | 11/9 | II | 7.2 (6–12) |  | 4, 6, 7 |
Flinkkilä et al. [40] | Finland | Retrospective | 2007–2012 | HP/CC | 40 (19/21) | 45 ± 13 | 39 ± 14 | 13/6 | 20/1 | II | 62 ± 21 | 32 ± 16 | 1, 4 |
Lu et al. [48] | China | Retrospective | 2009.5–2010.5 | HP/CC | 40 (19/21) | 34.3 ± 1.8 | 33.2 ± 1.5 | 11/8 | 11/10 | IIB | 12–24 |  | 1, 4, 8 |
Chen et al. [35] | China (TW) | Retrospective | 2004.12–2010.8 | HP/CC | 68 (28/40) | 48.3 (28–78) | 43.2 (18–75) | 16/12 | 28/12 | IIB | 37.4 (24–68) | 38.2 (24–64) | 4 |
Wu et al. [63] | China | Retrospective | 2008.1–2010.3 | HP/CC | 42 (30/12) | 37.5 ± 2.8 | 36.8 ± 1.5 | 22/8 | 9/3 | II | 12.6 (3–18) |  | 4, 5, 6, 7 |
Seo et al. [51] | Korea | Retrospective | 2011.1–2019.3 | HP/LCP + CC | 82 (54/28) | 43.9 ± 15.8 | 45.6 ± 18.2 | 35/19 | 18/10 | IIB | 18.7 ± 4.2 | 15.6 ± 2.1 | 1, 4, 6, 8 |
Hu et al. [68] | China | Retrospective | 2011.4–2018.5 | HP/LCP + CC | 42 (23/19) | 41.6 ± 13.2 |  | 14/9 | 12/7 | II | 17.5 ± 4.7 |  | 1, 3, 4, 6, 7, 8 |
Zeng et al. [64] | China | Retrospective | 2012–2016 | HP/LCP + CC | 39 (18/21) | 43.4 ± 13.9 | 41.7 ± 14.0 | 7/11 | 11/10 | IIB | 24.6 ± 6.6 |  | 1, 3, 4, 6, 7, 8 |
Helfen et al. [43] | Germany | Retrospective | 2011.11–2015.11 | HP/LCP + CC | 41 (21/20) | 39.7 ± 14.6 | 53 ± 17.5 | NR |  | IIB | NR |  | 1, 4 |
Lin et al. [66] | China | Retrospective | 2012.1–2015.1 | HP/LCP + CC | 65 (32/33) | 41.2 ± 9.9 | 42.6 ± 10.4 | 18/14 | 21/12 | IIB | 15.2 ± 2.1 | 14.6 ± 5.2 | 1, 4, 8 |
Gao et al. [42] | China | Retrospective | 2010.8–2013.8 | HP/LCP + CC | 42 (20/22) | 45.6 ± 12.4 | 44.2 ± 11.6 | 11/9 | 14/8 | IIB | 16.8 (10–24) |  | 1, 3, 4, 8 |
Bhatia et al. [33] | Australia | Retrospective | 2005–2008 | HP/LCP + CC | 15 (10/5) | 34.5 (20–57) | 13/2 |  | IIB | 26.1 (12–40) |  | 4 |  |
Dey Hazra et al. [37] | Germany | Retrospective | 2014–2017 | LCP/LCP + CC | 31 (14/17) | 43 ± 15 | 43 ± 17 | 9/5 | 9/8 | IIB | 29 ± 12.4 | 18 ± 7.1 | 1, 3, 4, 6 |
Salazar et al. [14] | USA | Retrospective | 2009–2019 | LCP/LCP + CC | 23 (16/7) | 42 ± 13 | 45 ± 13 | 14/2 | 5/2 | II, V | 28 ± 34 | 47 ± 39 | 4 |
Zhang et al. [61] | China | Retrospective | 2013.1–2015.1 | LCP/LCP + CC | 40 (20/20) | 37.3 ± 10.6 | 40.6 ± 12.6 | 16/4 | 15/5 | IIB | 30.1 ± 6.7 |  | 1, 3, 4, 5, 6, 7, 8 |
Xu et al. [15] | China | Retrospective | 2010.2–2017.1 | LCP/LCP + CC | 34 (16/18) | 50.7 ± 17.7 | 45.5 ± 14.4 | 9/7 | 12/6 | IIB | 16.0 | 17.5 | 1, 4, 8 |
Tang et al. [54] | China | Retrospective | 2013.2–2017.1 | LCP/LCP + CC | 40 (22/18) | 45.4 (26–65) | 43.3 (24–61) | 10/12 | 11/7 | IIB | 16.3 (12–27) |  | 1, 4, 6 |
Fan et al. [39] | China | Retrospective | 2013.1–2015.1 | LCP/LCP + CC | 28 (10/18) | 40.2 ± 12.6 | 36.9 ± 11.0 | 7/3 | 14/4 | II | 21.8 ± 7.7 | 18.4 ± 3.6 | 1, 2, 3, 4, 5, 6, 7, 8 |
Mechchat et al. [49] | Morocco | Prospective | 2009–2013 | HP/KWTB | 26 (14/12) | 34.2 ± 13.7 | 29 ± 13.7 | 8/6 | 5/7 | II | 12 |  | 1, 4, 8 |
Wu et al. [57] | China (TW) | Retrospective | 2007.1–2010.6 | HP/KWTB | 116 (92/24) | 49.3 ± 15.5 | 50.7 ± 17.6 | 55/37 | 17/7 | II | 22.8 ± 2.2 | 25.7 ± 2.8 | 1, 4 |
Hsu et al. [45] | China (TW) | RCT | 2005.2–2008.11 | HP/KWTB | 65 (35/30) | 43.2 ± 12.8 | 41.3 ± 13.6 | 23/12 | 21/9 | II | 6 |  | 4 |
Lee et al. [46] | China (TW) | Retrospective | 2000–2007 | HP/KWTB | 52 (32/20) | 43.4 | 35.9 | 18/14 | 9/11 | II | 24.3 | 29.8 | 1, 4 |
Flinkkilä et al. [41] | Finland | Retrospective | 1988–1999 | HP/KWTB | 39 (17/22) | 43 (18–71) | 35 (17–68) | 16/1 | 16/6 | II | 24 | 74.4 | 4 |
Tsuei et al. [55] | China (TW) | Retrospective | 2002–2008 | KW/KWTB | 29 (14/15) | 39.2 ± 15.0 | 39.3 ± 14.1 | 9/5 | 11/4 | II | 8.62 (6–20) |  | 2, 4, 6, 8 |
Seyhan et al. [16] | Turkey | Retrospective | 2000–2011 | KWTB + CC/LCP + CC | 24 (10/14) | 36.1 (20–55) |  | 6/4 | 10/4 | IIB | NR |  | 1, 4 |